1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PDZD4 CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA CCP110 CTRPv2 pan-cancer AAC 0.18 5e-08
mRNA NABP1 CTRPv2 pan-cancer AAC -0.18 6e-08
mRNA SCAF4 CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA HSF2 CTRPv2 pan-cancer AAC 0.18 6e-08
mRNA RAB39A CTRPv2 pan-cancer AAC 0.19 6e-08
mRNA ANXA5 CTRPv2 pan-cancer AAC -0.24 6e-08
mRNA HNRNPDL CTRPv2 pan-cancer AAC 0.2 7e-08
mRNA ZNF124 CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA REV3L CTRPv2 pan-cancer AAC 0.18 7e-08
Download CSV